• Aucun résultat trouvé

2.3 QUALITY OVERALL SUMMARY INTRODUCTION

N/A
N/A
Info
Télécharger
Protected

Academic year: 2022

Partager "2.3 QUALITY OVERALL SUMMARY INTRODUCTION"

Copied!
1
0
0

Chargement.... (Voir le texte intégral maintenant)

Texte intégral

(1)

Travoprost/ Pharmathen 40 micrograms/mL preservative free eye drops, solution in multi dose container

2.3 Quality Overall Summary, p.1

2.3 QUALITY OVERALL SUMMARY INTRODUCTION

Drug Substance Proprietary name: Travoprost

Drug Substance Non-proprietary name (INN): Travoprost

Drug Product:

Drug Product Manufacturer:

.

Drug Product Dosage Forms: Eyes, drops solution

Strengths: 40 micrograms/ml

Route of administration: Topical Proposed indication:

Travoprost/ Pharmathen 40 micrograms/mL preservative free eye drops, solution in multi dose container decrease the elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.

Références

Télécharger maintenant ( PDF - 1 Page - 32.90 KB )

Documents relatifs

(1)Travoprost-Timolol / Pharmathen (40micrograms/mL+5mg/mL) preservative free eye drops, solution in multi dose container 1.5.2 Information for abridged application 1 1.5

Profile comparison between Travoprost Timolol 0.04mg/ml – 5mg/ml eye drops solution preservative free and DUOTRAV reference products (ALCON) reveals similarity between the

[TRAVOPROST + TIMOLOL] 40 MCG/ML + 5 MG/ML, PRESERVATIVE-FREE EYE DROPS, SOLUTION RISK MANAGEMENT PLAN

Five clinical studies were conducted for DuoTrav 40 micrograms/mL + 5 mg/mL eye drops, solution (Alcon Laboratories) to support the efficacy and safety of the

Module 2.5: Clinical Overview Travoprost/Timolol preservative free eye drops solution by Pharmathen

A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary

Medical Device Not applicable - Certificates of Suitability Please refer to dossier section 32-reg-info for the current Certificate of Suitability of Timolol maleate

Process validation protocol for Travoprost-Timolol/Pharmathen (40 micrograms/mL + 5 mg/ml) preservative free eye drops, solution in multi dose container is enclosed in

RISK MANAGEMENT PLAN [LATANOPROST] 50 MCG/ML PRESERVATIVE FREE EYE DROPS, SOLUTION

[LATANOPROST] 50 mcg/ml preservative free eye drops, solution is indicated for thereduction of elevated intraocular pressure in patients with open angle glaucoma and

2.2 Introduction International Nonproprietary Name (rINN): Latanoprost Structural formula: Molecular formula:

Latanoprost/ Pharmathen 50 micrograms /mL preservative free eye drops, solution in multi dose container 2.2 Introduction, p.1..

For a bibliographical research report on all studies carried out on latanoprost please refer to Module 5 of this application.

Latanoprost/Pharmathen 50 µg/mL preservative free eye drops, solution is indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma and

Vizitrav Duo (travoprost + timolol maleate), 40 micrograms/mL + 5 mg/mL eye drops, solution

Gerhard